Home Transgenomic

Transgenomic

In operation
IPO Delisting
Molecular Genetics and Diagnostics Developer

Basic Information

Transgenomic, Inc. (Transgenomic) provides nucleic acid purification and analysis products for the life sciences industry, used in molecular genetics and diagnostics research. The company also offers genetic variation analysis services for medical research, clinical, and pharmaceutical markets. Transgenomic, Inc. is a global biotechnology company that promotes personalized medicine in cardiology, oncology, and genetic disorders through its proprietary molecular technologies and world-class clinical and research services. With a range of innovative products, including its flagship C-GAAP test, the company has become a global leader in cardiac genetic testing; the C-GAAP test is designed to detect genetic mutations indicative of heart disease or those that may lead to severe adverse events.
Transgenomic, Inc.
Omaha,Nebraska,United States of America
101~500 people
January 01, 1997
info@transgenomic.com